-
Tennessee woman accused of selling fake weight loss drugs as counterfeit concerns grow
The woman was accused of selling counterfeit versions of popular weight loss drugs including Ozempic and Wegovy. Experts say fakes have exploded in the U.S.
-
Trump's tariffs could raise the cost of generic drugs in the U.S.
The cost of generic drugs for many people could go up if President-elect Donald Trump follows through on his promise to impose sweeping tariffs on products from China and other foreign countries, policy experts say.
-
Clinical trials sparking hope for Alzheimer's patients: ‘Holding my own'
A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making symptom-improving medication more accessible for people experiencing mild cognitive impairment.
-
Surgeons in Philadelphia successfully separate conjoined twin boys
After spending nearly a year at Children’s Hospital of Philadelphia, conjoined twins Amari and Javar Ruffin were successfully separated.
-
Remember the prescription drug shortages from last year? The problem hasn't gone away
Forty years after the Hatch-Waxman Act created a market for affordable generic versions of prescription medications, it is struggling with persistent shortages.
-
-
Maker of Ozempic and Wegovy faces grilling over high cost of weight loss drugs
Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday on Capitol Hill.
-
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
The late-stage trial on tirzepatide also found that patients experienced sustained weight loss over the roughly three-year treatment period.
-
US challenges ‘bogus' patents on Ozempic and other drugs in effort to spur competition
Federal regulators on Tuesday sent warning letters to several drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other respiratory conditions.
-
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It's not that clear-cut
President Joe Biden often overstates what people who are eligible for the price cap for insulin paid previously.
-
3 signs it's time to break up with your doctor—'your health is one of your most important assets,' physician says
A doctor who was once a good fit might not always meet the needs you have now. Here are some signs that it’s time to find a new one.
-
ADHD medication recalled after antihistamine mistakenly found in pill bottles
A drug company is recalling some of its ADHD and narcolepsy medication because the bottles may contain the wrong pills inside. The U.S. Food and Drug Administration said in a notice published last week that Azurity Pharmaceuticals is recalling one lot of Zenzedi 30-milligram dextroamphetamine sulfate tablets. The move comes after a pharmacist in Nebraska found carbinoxamine maleate tablets,...
-
Many states are expanding their Medicaid programs to provide dental care to their poorest residents
A growing number of states are offering dental care to low-income adults who once had to rely on charity or the emergency room to treat their tooth problems.
-
Patients need doctors who look like them. Can medicine diversify without affirmative action?
After the Supreme Court struck down affirmative action in college admissions, concerns have arisen that a pathway into medicine may become much harder for students of color. Heightening the alarm: the medical field’s reckoning with longstanding health inequities.
-
‘Dinner plate-sized' medical tool found inside woman 18 months after she gave birth
A medical device the size of a dinner plate was left inside a woman’s abdomen for 18 months.
-
Doctors find live worm in Australian woman's brain: ‘We all felt a bit sick'
A neurosurgeon investigating a woman’s mystery symptoms in an Australian hospital has plucked an 8-centimeter (3-inch) wriggling worm from the patient’s brain.
-
Pig kidney works in a donated body for over a month, a step toward animal-human transplants
New York surgeons transplanted a pig’s kidney into a brain-dead man and for over a month it’s worked normally.
-
Some insurers won't cover new Alzheimer's treatment shown to slow decline
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients.
-
Biotech company settles with family of Henrietta Lacks, whose cells uphold medicine
More than 70 years after doctors at Johns Hopkins Hospital took Henrietta Lacks’ cervical cells without her knowledge, a lawyer for her descendants said they have reached a settlement with a biotechnology company they sued in 2021, accusing its leaders of reaping billions of dollars from a racist medical system.